EWH vs IBB

iShares MSCI Hong Kong ETF vs iShares Biotechnology ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.50% for EWH.
  • EWH pays a higher dividend yield (4.68%).

Side-by-side metrics

MetricEWHIBB
Expense ratio
Annual fee. Lower is better.
0.50%0.44%
Dividend yield
Trailing 12-month yield.
4.68%0.23%
AUM
Assets under management — bigger funds are typically more liquid.
$927M$7.95B
YTD return
14.78%3.10%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.780.74
P/E ratio
19.0823.72
Last price
$24.34$170.10
Inception
Issuer
iSharesiShares

EWH top holdings

Top holdings · EWH
1299.HKAIA Group Ltd23.32%
0388.HKHong Kong Exchanges and Clearing Ltd14.83%
0001.HKCK Hutchison Holdings Ltd5.47%
2388.HKBOC Hong Kong Holdings Ltd4.65%
0016.HKSun Hung Kai Properties Ltd4.55%
0669.HKTechtronic Industries Co Ltd4.11%
0002.HKCLP Holdings Ltd3.95%
0823.HKLink Real Estate Investment Trust3.35%
1113.HKCK Asset Holdings Ltd3.09%
0006.HKPower Assets Holdings Ltd2.96%
Sector breakdown · EWH
Real Estate18.6%
Consumer Cyclical3.7%
Consumer Defensive2.7%
Communication Services1.7%
Financial Services45.4%
Utilities11.2%
Industrials16.6%

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

About EWH

EWH (iShares MSCI Hong Kong ETF) is Hong Kong large and mid-cap equities. Managed by iShares, the fund carries $927M in assets under management, an expense ratio of 0.50%, a dividend yield of 4.68%. Its largest holding is AIA Group Ltd (1299.HK), which represents 23.3% of the portfolio. Real Estate is the fund's largest sector exposure at 18.6%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.